Overview

Study Review: The Duration of Denosumab Treatment and the Efficacy of Zoledronate to Preserve Bone Mineral Density After Its Discontinuation - presented by Sarang Patel, MD

Accreditation

HealthPartners is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

HealthPartners Office of Continuing Medical Education designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Objectives

Regularly attending this series will allow participants to be able to:

• Apply best practices in diagnosis and recognition of endocrine conditions including but not limited to thyroid disease, adrenal disease, diabetes mellitus, gonadal disease, pituitary disease
• Review strategies for treatment and management of endocrine conditions
• Analyze and discuss the pathophysiology of endocrine conditions